Detection of Replication Competent Retrovirus and Lentivirus
Authors:
- 1 January 2009
- book chapter
- Published by Springer Nature
- Vol. 506, 243-263
Abstract
Retroviral vectors based on murine leukemia viruses (MuLV) have been used in clinical investigations for over a decade. Alternative retroviruses, most notably vectors based on HIV-1 and other lentiviruses, are now entering into clinical trials. Although vectors are designed to be replication defective, recombination events during vector production could lead to the generation of replication competent retroviruses (RCR) or replication competent lentiviruses (RCL). Careful screening of vector prior to human use must insure that patients are not inadvertently exposed to RCR or RCL. We describe methods capable of detecting low levels of virus contamination and discuss the current regulatory guidelines for screening gene therapy products intended for human use.Keywords
This publication has 60 references indexed in Scilit:
- Gene Therapy Insertional Mutagenesis InsightsScience, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Safety Testing for Replication-Competent Retrovirus Associated with Gibbon Ape Leukemia Virus-Pseudotyped Retroviral VectorsHuman Gene Therapy, 2001
- Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector systemGene Therapy, 1999
- Biosafety Monitoring of Patients Receiving Intracerebral Injections of Murine Retroviral Vector Producer CellsHuman Gene Therapy, 1998
- Evaluation of Recommendations for Replication-Competent Retrovirus Testing Associated with Use of Retroviral VectorsHuman Gene Therapy, 1997
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Infection of Human Cells with Murine Amphotropic Replication-Competent RetrovirusesHuman Gene Therapy, 1993
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.Journal of Experimental Medicine, 1992